These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1119 related articles for article (PubMed ID: 3652030)

  • 1. Azelaic acid as a competitive inhibitor of thioredoxin reductase in human melanoma cells.
    Schallreuter KU; Wood JM
    Cancer Lett; 1987 Sep; 36(3):297-305. PubMed ID: 3652030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The stereospecific suicide inhibition of human melanoma thioredoxin reductase by 13-cis-retinoic acid.
    Schallreuter KU; Wood JM
    Biochem Biophys Res Commun; 1989 Apr; 160(2):573-9. PubMed ID: 2719682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A possible mechanism of action for azelaic acid in the human epidermis.
    Schallreuter KU; Wood JW
    Arch Dermatol Res; 1990; 282(3):168-71. PubMed ID: 2114832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of calcium in the regulation of free radical reduction by thioredoxin reductase at the surface of the skin.
    Schallreuter KU; Pittelkow MR; Gleason FK; Wood JM
    J Inorg Biochem; 1986; 28(2-3):227-38. PubMed ID: 2433392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthralin inhibits elevated levels of thioredoxin reductase in psoriasis. A new mode of action for this drug.
    Schallreuter KU; Pittelkow MR
    Arch Dermatol; 1987 Nov; 123(11):1494-8. PubMed ID: 2445297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism of action of the nitrosourea anti-tumor drugs on thioredoxin reductase, glutathione reductase and ribonucleotide reductase.
    Schallreuter KU; Gleason FK; Wood JM
    Biochim Biophys Acta; 1990 Aug; 1054(1):14-20. PubMed ID: 2200526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of azelaic acid on cultures of lymphoma- and leukemia-derived cell lines, normal resting and stimulated lymphocytes and 3T3 fibroblasts.
    Picardo M; Passi S; Sirianni MC; Fiorilli M; Russo GD; Cortesi E; Barile G; Breathnach AS; Nazzaro-Porro M
    Biochem Pharmacol; 1985 May; 34(10):1653-8. PubMed ID: 4004885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of DNA synthesis of melanoma cells by azelaic acid.
    Leibl H; Stingl G; Pehamberger H; Korschan H; Konrad K; Wolff K
    J Invest Dermatol; 1985 Nov; 85(5):417-22. PubMed ID: 4056455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastructural observations on the effect of azelaic acid on normal human melanocytes and a human melanoma cell line in tissue culture.
    Robins EJ; Breathnach AS; Bennett D; Ward BJ; Bhasin Y; Ethridge L; Nazzaro-Porro M; Passi S; Picardo M
    Br J Dermatol; 1985 Dec; 113(6):687-97. PubMed ID: 4096883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dicarboxylic acids on Harding-Passey and Cloudman S91 melanoma cells in tissue culture.
    Robins EJ; Breathnach AS; Ward BJ; Bhasin YP; Ethridge L; Nazzaro-Porro M; Passi S; Picardo M
    J Invest Dermatol; 1985 Sep; 85(3):216-21. PubMed ID: 4031537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of thioredoxin reductase (E.C. 1.6.4.5.) by antitumor quinones.
    Mau BL; Powis G
    Free Radic Res Commun; 1990; 8(4-6):365-72. PubMed ID: 2162313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dicarboxylic acids (C6 and C9) on human choroidal melanoma in cell culture.
    Breathnach AS; Robins EJ; Pätzold HC; Bhasin YP; Ethridge LB; Garner A; Nazzaro-Porro M
    Invest Ophthalmol Vis Sci; 1989 Mar; 30(3):491-8. PubMed ID: 2925320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activity and purification of membrane-associated thioredoxin reductase from human metastatic melanotic melanoma.
    Schallreuter KU; Wood JM
    Biochim Biophys Acta; 1988 Oct; 967(1):103-9. PubMed ID: 2844280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of the effectiveness of azelaic acid as a depigmenting and chemotherapeutic agent.
    Pathak MA; Ciganek ER; Wick M; Sober AJ; Farinelli WA; Fitzpatrick TB
    J Invest Dermatol; 1985 Sep; 85(3):222-8. PubMed ID: 4031538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of azelaic acid as a depigmenting and chemotherapeutic agent.
    Robins EJ; Breathnach AS; Bashin YP; Ethridge L; Nazzaro-Porro M; Passi S; Picardo M
    J Invest Dermatol; 1986 Aug; 87(2):293-4. PubMed ID: 3734479
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of azelaic acid on the growth of melanoma cell cultures in comparison with fibroblast cultures].
    Geier G; Hauschild T; Bauer R; Kreysel HW
    Hautarzt; 1986 Mar; 37(3):146-8. PubMed ID: 3700102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity and resistance in human metastatic melanoma to the new chloroethylnitrosourea anti-tumor drug Fotemustine.
    Schallreuter KU; Wood JM
    Biochim Biophys Acta; 1991 Jun; 1096(4):277-83. PubMed ID: 2065101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scanning electron microscopy of human and murine melanoma cells exposed to medium chain-length (C6-C12) dicarboxylic acids in tissue culture.
    Breathnach AS; Robins EJ; Bhasin Y; Ethridge L; Nazzaro-Porro M; Passi S; Picardo M
    Histol Histopathol; 1987 Jul; 2(3):291-7. PubMed ID: 2980732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid.
    Stamatiadis D; Bulteau-Portois MC; Mowszowicz I
    Br J Dermatol; 1988 Nov; 119(5):627-32. PubMed ID: 3207614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of L-carnitine on cultured murine melanoma cells exposed to azelaic acid.
    Ward BJ; Breathnach AS; Robins EJ; Bhasin YP; Ethridge L; Nazzaro-Porro M; Passi S
    J Invest Dermatol; 1986 Apr; 86(4):438-41. PubMed ID: 3745962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.